“…For diagnostic purposes, better treatment results, and expanding our knowledge of mycobacterial diseases, it is necessary to identify and classify new species/subspecies of NTM [28,57,58]. Describing the complete genomes of the novel NTM requires a combination of short-read (e.g., Illumina MiSeq, San Diego, CA, USA) and long-read (e.g., MinION, Oxford, UK; PacBio SMRT, Pacific Biosciences, CA, USA) sequencing technologies (Figure 1 and Table 1) [59]. Short-read sequencing is characterized by high accuracy but does not provide information about the complete genome (including G + C rich regions, recombination, repetitive PE/PPE regions, deletions, and insertions) [60].…”